An in-depth look to GENOVATE BIOTECHNOLOGY CO. LTD. operating, investing, and financing activities

4130 free cash flow for Q3 24 is 13.12 M TWD. For 2023, 4130 free cash flow was 71.71 M TWD and operating cash flow was 99.69 M TWD.